ClinicalTrialsFinder
RecruitingNCT06851910

Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia

Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia: A Prospective Observational Study

Sponsor

Hospital Universitari de Bellvitge

Enrollment

20 participants

Start Date

Apr 21, 2025

Study Type

OBSERVATIONAL

Conditions

Trigeminal Neuralgia

Summary

This prospective observational study evaluates the effectiveness and safety of intravenous lacosamide as a rescue treatment for acute pain in patients presenting to the emergency department with trigeminal neuralgia

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Lacosamide for people with trigeminal neuralgia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLacosamide

Patients will be included if they are prescribed intravenous lacosamide for their trigeminal neuralgia exacerbation

Locations(1)

Hospital de Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06851910

Related Trials

RP-008 in Combination With Daily Oral Varenicline for the Treatment of Trigeminal Neuralgia

NCT075964851 location

Neurosurgical Outcome Network

NCT0672402927 locations

The Will Erwin Headache Research Center - Cluster Headache Study

NCT029103231 location

OnabotulinumtoxinA for Trigeminal Neuralgia

NCT062168861 location

Trigeminal Evoked Responses to Improve Rhizotomy

NCT057380961 location